Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 5.52
(-0.18%)
CNY 5.52
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 134.42 Million | 108.93 Million | 119.05 Million | 135.55 Million | 124.64 Million | 81.02 Million |
| Net Income | 15.33 Million | -36.03 Million | 47.18 Million | -29.42 Million | 27.96 Million | 62.15 Million |
| Depreciation & Amortization | 61.69 Million | 62.9 Million | 58.94 Million | 52.17 Million | 44.09 Million | 40.56 Million |
| Deferred income taxes | -7.8 Million | -3.86 Million | -5.04 Million | 521.54 Thousand | -10.04 Million | -3.72 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 17.31 Million | 21.94 Million | -15.57 Million | 43.12 Million | 15.6 Million | -62.03 Million |
| Other non-cash items | 153.94 Million | 60.11 Million | 28.5 Million | 69.68 Million | 36.98 Million | 40.32 Million |
| Investing Cash Flow | -355.45 Million | -213.11 Million | -42.33 Million | -23.7 Million | -25.88 Million | -16.12 Million |
| Investments in PPE | -18.68 Million | -39.11 Million | -44.5 Million | -28.39 Million | -26.27 Million | -12.24 Million |
| Acquisitions | 1.5 Million | 589.29 Thousand | 3.39 Million | 5.01 Million | 3.72 Million | 1.9 Million |
| Investment purchases | -878.26 Million | -808.82 Million | -3.39 Million | -375 Thousand | -9.75 Million | -6.02 Million |
| Sales/Maturities of investments | 540 Million | 634.24 Million | 26.85 Thousand | 28.43 Million | 6 Million | 12.48 Million |
| Other Investing Activities | -334.64 Million | 1.02 | 2.14 Million | -28.39 Million | 422.74 Thousand | -12.24 Million |
| Financing Cash Flow | -12.25 Million | -24.76 Million | 499.14 Million | -45.74 Million | -82.59 Million | -99.98 Million |
| Debt repayment | -7.93 Million | -10.84 Million | -49.84 Million | -20.32 Million | -113.23 Million | -112.93 Million |
| Dividends payments | -201.32 Thousand | -10.87 Million | -403.11 Thousand | -4.17 Million | -5.78 Million | -18.96 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -4.12 Million | -3.03 Million | 549.39 Million | -17.9 Million | 36.42 Million | 31.91 Million |
| Accounts receivables | 43.97 Million | 6.25 Million | 2.85 Million | 638.42 Thousand | 60.4 Million | -14.52 Million |
| Accounts payables | -34.44 Million | 16.68 Million | 11.86 Million | 46.95 Million | -49.32 Million | -41.12 Million |
| Inventory | 7.77 Million | 2.88 Million | -25.24 Million | -4.98 Million | 14.57 Million | -2.66 Million |
| Other working capital | -1.00 | -3.86 Million | -5.04 Million | 521.03 Thousand | -10.04 Million | -59.37 Million |
| Cash at beginning of period | 798.81 Million | 927.35 Million | 351.3 Million | 285.19 Million | 269.02 Million | 304.11 Million |
| Cash at end of period | 565.02 Million | 798.27 Million | 927.35 Million | 351.3 Million | 285.19 Million | 269.02 Million |
| Capital Expenditure | -18.68 Million | -39.11 Million | -44.5 Million | -28.39 Million | -26.27 Million | -12.24 Million |
| Effect of forex changes on cash | -493.12 Thousand | -132.21 Thousand | 171.18 Thousand | - | - | - |
| Net cash flow / Change in cash | -233.78 Million | -129.07 Million | 576.04 Million | 66.11 Million | 16.17 Million | -35.09 Million |
| Free Cash Flow | 115.73 Million | 69.81 Million | 74.55 Million | 107.16 Million | 98.37 Million | 68.77 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 465.47 Thousand | 3.31 Million | -2.7 Million | 15.33 Million | -8.42 Million | 7.27 Million |
| Depreciation & Amortization | - | 17.17 Million | 17.17 Million | 61.69 Million | 19.93 Million | 19.93 Million |
| Deferred income taxes | - | - | - | -7.8 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 23.89 Million | - | 17.31 Million | 51.75 Million | -39.67 Million |
| Other non-cash items | 32.94 Million | 32.25 Million | 12.27 Million | 153.94 Million | -46.08 Million | 62.77 Million |
| Investing Cash Flow | -371.64 Million | 1.78 Million | 163.18 Million | -355.45 Million | -67.08 Million | 29.38 Million |
| Investments in PPE | -2.5 Million | 1.78 Million | -17.8 Million | -18.68 Million | -6.13 Million | -2.51 Million |
| Acquisitions | - | - | 950 Thousand | 1.5 Million | 1.5 Million | - |
| Investment purchases | -490 Million | -310 Million | - | -878.26 Million | -342.44 Million | -230 Million |
| Sales/Maturities of investments | 120.85 Million | 310 Million | 180 Million | 540 Million | 280 Million | 261.89 Million |
| Other Investing Activities | - | 2.76 Million | 37 Thousand | -334.64 Million | -1.00 | 31.89 Million |
| Financing Cash Flow | -1.06 Million | -13.92 Million | -1.13 Million | -12.25 Million | -1.84 Million | -3.69 Million |
| Debt repayment | - | - | - | -7.93 Million | -4.12 Million | -2.67 Million |
| Dividends payments | -5.44 Million | -5.44 Million | - | -201.32 Thousand | -23.93 Thousand | -34.2 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.06 Million | -6.21 Million | -1.13 Million | -4.12 Million | -1.82 Million | -985.99 Thousand |
| Accounts receivables | - | 27 Million | - | 43.97 Million | 43.97 Million | -36.86 Million |
| Accounts payables | - | - | - | -34.44 Million | - | - |
| Inventory | - | -3.1 Million | - | 7.77 Million | 7.77 Million | -2.81 Million |
| Other working capital | - | - | - | -1.00 | - | - |
| Cash at beginning of period | 742.35 Million | 736.64 Million | 565.02 Million | 798.81 Million | 617.27 Million | 542.64 Million |
| Cash at end of period | 392.19 Million | 742.35 Million | 736.64 Million | 565.02 Million | 565.02 Million | 616.73 Million |
| Capital Expenditure | -2.5 Million | 1.78 Million | -17.8 Million | -18.68 Million | -6.13 Million | -2.51 Million |
| Effect of forex changes on cash | - | - | - | -493.12 Thousand | -492.85 Thousand | -1.89 Million |
| Net cash flow / Change in cash | -350.15 Million | 5.71 Million | 171.61 Million | -233.78 Million | -52.24 Million | 74.09 Million |
| Free Cash Flow | 30.9 Million | 20.17 Million | -8.23 Million | 115.73 Million | 11.04 Million | 47.78 Million |
ACNB
3178
6793
5284
3596
1324